205 related articles for article (PubMed ID: 11527645)
21. Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate.
Gori T; Daiber A
Am J Cardiovasc Drugs; 2009; 9(1):7-15. PubMed ID: 19178128
[TBL] [Abstract][Full Text] [Related]
22. The angiotensin II-receptor antagonist losartan does not prevent hemodynamic or vascular tolerance to nitroglycerin.
Milone SD; Azevedo ER; Forster C; Parker JD
J Cardiovasc Pharmacol; 1999 Nov; 34(5):645-50. PubMed ID: 10547079
[TBL] [Abstract][Full Text] [Related]
23. Fetal programming effects of pentaerythritol tetranitrate in a rat model of superimposed preeclampsia.
Man AWC; Chen M; Zhou Y; Wu Z; Reifenberg G; Daiber A; Münzel T; Xia N; Li H
J Mol Med (Berl); 2020 Sep; 98(9):1287-1299. PubMed ID: 32748067
[TBL] [Abstract][Full Text] [Related]
24. Biochemical, hemodynamic, and vascular evidence concerning the free radical hypothesis of nitrate tolerance.
Milone SD; Pace-Asciak CR; Reynaud D; Azevedo ER; Newton GE; Parker JD
J Cardiovasc Pharmacol; 1999 May; 33(5):685-90. PubMed ID: 10226853
[TBL] [Abstract][Full Text] [Related]
25. Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans.
Gori T; Mak SS; Kelly S; Parker JD
J Am Coll Cardiol; 2001 Oct; 38(4):1096-101. PubMed ID: 11583888
[TBL] [Abstract][Full Text] [Related]
26. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
[No Abstract] [Full Text] [Related]
27. In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits.
Kojda G; Stein D; Kottenberg E; Schnaith EM; Noack E
J Cardiovasc Pharmacol; 1995 May; 25(5):763-73. PubMed ID: 7543171
[TBL] [Abstract][Full Text] [Related]
28. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy.
Parker JO; Parker JD; Caldwell RW; Farrell B; Kaesemeyer WH
J Am Coll Cardiol; 2002 Apr; 39(7):1199-203. PubMed ID: 11923046
[TBL] [Abstract][Full Text] [Related]
29. [PETN: long acting nitrate with tolerance devoiding properties and innovative potential].
Richartz BM; Schneider HT; Silber S
MMW Fortschr Med; 2008 Apr; 150 Suppl 1():43-7. PubMed ID: 18540332
[No Abstract] [Full Text] [Related]
30. Comparison of the effects of pentaerythritol tetranitrate and nitroglycerin on endothelium-dependent vasorelaxation in male volunteers.
Gori T; Al-Hesayen A; Jolliffe C; Parker JD
Am J Cardiol; 2003 Jun; 91(11):1392-4. PubMed ID: 12767446
[No Abstract] [Full Text] [Related]
31. [Comparative study of three oral nitrate derivatives. A hemodynamic assessment in 10 patients with chronic heart failure (author's transl)].
Bory M; Clavier P; Arnoux F; Djiane P; Egre A; Serradimigni A
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2437-42. PubMed ID: 6775296
[TBL] [Abstract][Full Text] [Related]
32. Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension.
Steven S; Oelze M; Brandt M; Ullmann E; Kröller-Schön S; Heeren T; Tran LP; Daub S; Dib M; Stalleicken D; Wenzel P; Münzel T; Daiber A
Oxid Med Cell Longev; 2017; 2017():4353462. PubMed ID: 28337251
[No Abstract] [Full Text] [Related]
33. Characterization of the antioxidant properties of pentaerithrityl tetranitrate (PETN)-induction of the intrinsic antioxidative system heme oxygenase-1 (HO-1).
Daiber A; Münzel T
Methods Mol Biol; 2010; 594():311-26. PubMed ID: 20072927
[TBL] [Abstract][Full Text] [Related]
34. Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels.
Hink U; Daiber A; Kayhan N; Trischler J; Kraatz C; Oelze M; Mollnau H; Wenzel P; Vahl CF; Ho KK; Weiner H; Munzel T
J Am Coll Cardiol; 2007 Dec; 50(23):2226-32. PubMed ID: 18061070
[TBL] [Abstract][Full Text] [Related]
35. Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice.
Wenzel P; Hink U; Oelze M; Seeling A; Isse T; Bruns K; Steinhoff L; Brandt M; Kleschyov AL; Schulz E; Lange K; Weiner H; Lehmann J; Lackner KJ; Kawamoto T; Münzel T; Daiber A
Br J Pharmacol; 2007 Feb; 150(4):526-33. PubMed ID: 17220910
[TBL] [Abstract][Full Text] [Related]
36. Effects of nitroglycerin or pentaerithrityl tetranitrate treatment on the gene expression in rat hearts: evidence for cardiotoxic and cardioprotective effects.
Pautz A; Rauschkolb P; Schmidt N; Art J; Oelze M; Wenzel P; Förstermann U; Daiber A; Kleinert H
Physiol Genomics; 2009 Jul; 38(2):176-85. PubMed ID: 19417013
[TBL] [Abstract][Full Text] [Related]
37. Effects of nonintermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and superoxide production.
Kojda G; Hacker A; Noack E
Eur J Pharmacol; 1998 Aug; 355(1):23-31. PubMed ID: 9754935
[TBL] [Abstract][Full Text] [Related]
38. Continuous therapy with nitroglycerin impairs endothelium-dependent vasodilation but does not cause tolerance in conductance arteries: a human in vivo study.
Gori T; Harvey P; Floras JS; Parker JD
J Cardiovasc Pharmacol; 2004 Nov; 44(5):601-6. PubMed ID: 15505499
[TBL] [Abstract][Full Text] [Related]
39. Lack of tolerance in forearm blood vessels in man to glyceryl trinitrate.
Cheesman AR; Benjamin N
Br J Clin Pharmacol; 1994 May; 37(5):441-4. PubMed ID: 8054249
[TBL] [Abstract][Full Text] [Related]
40. [Therapy with NO donors-antiatherogenic and antioxidant actions].
Grosser N; Schröder H
Herz; 2004 Feb; 29(1):116-22. PubMed ID: 14968347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
